Although further studies are needed, our findings suggest that NTS/NTSR1 signaling contributes to the acquisition of a malignant phenotype by pancreatic cancer cells through the induction of EMT and inflammation. The gene discussed is NTSR1; the disease is familial pancreatic carcinoma.